Literature DB >> 20107173

Association of POAG risk factors and the Thr377Met MYOC mutation in an isolated Greek population.

Mary K Wirtz1, John R Samples, Victoria Toumanidou, Jac Charlesworth, Dimitrios G Mikropoulos, Konstantinos Kaltsos, Athanasios Economou, Antonios Dimopoulos, Irene N Georgiadou, Georgios Moumtzis, Athanasios Papanastasiou, Patricia L Kramer, Tom Dyer, John Blangero, Anastasios G P Konstas.   

Abstract

PURPOSE: To characterize the MYOC genotype correlation with phenotypes in an isolated Greek population with a high incidence of glaucoma.
METHODS: Five hundred thirty-one villagers were enrolled in the study. Participants underwent a comprehensive ophthalmic examination. All three exons of myocilin were bidirectionally sequenced. Power calculations and measured genotype analysis was conducted using the genetic variance analysis program, SOLAR version 4.2, to account for the relatedness between individuals.
RESULTS: The participants, 376 of whom were linked in a single 11-generation pedigree, ranged in age from 10 to 95 years with a mean age of 49. Sixty-five individuals had POAG, and 27 of those carried the Thr377Met MYOC mutation. Both peak intraocular pressure and vertical cup-to dis- ratio were significantly associated with the MYOC Thr377Met variant (P = 9 x 10(-14) and P = 9 x 10(-8), respectively), whereas central corneal thickness showed no significant association (P < 0.7).
CONCLUSIONS: This village had a high frequency of glaucoma, with 12% of the participants aged 10 to 95 years having the disease. In this cohort, the Thr377Met MYOC mutation was significantly associated with both high intraocular pressures and high vertical cup-to-disc ratios. No association was found with central corneal thickness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107173      PMCID: PMC2891465          DOI: 10.1167/iovs.09-4652

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  37 in total

Review 1.  The definition and classification of glaucoma in prevalence surveys.

Authors:  Paul J Foster; Ralf Buhrmann; Harry A Quigley; Gordon J Johnson
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Adult-onset primary open-angle glaucoma caused by mutations in optineurin.

Authors:  Tayebeh Rezaie; Anne Child; Roger Hitchings; Glen Brice; Lauri Miller; Miguel Coca-Prados; Elise Héon; Theodore Krupin; Robert Ritch; Donald Kreutzer; R Pitts Crick; Mansoor Sarfarazi
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

3.  Prevalence of open-angle glaucoma among adults in the United States.

Authors:  David S Friedman; Roger C W Wolfs; Benita J O'Colmain; Barbara E Klein; Hugh R Taylor; Shelia West; M Cristina Leske; Paul Mitchell; Nathan Congdon; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

4.  A large GLC1C Greek family with a myocilin T377M mutation: inheritance and phenotypic variability.

Authors:  Michael B Petersen; George Kitsos; John R Samples; N Donna Gaudette; Effrosini Economou-Petersen; Renée Sykes; Kristal Rust; Maria Grigoriadou; George Aperis; Dongseok Choi; Konstantinos Psilas; Jamie E Craig; Patricia L Kramer; David A Mackey; Mary K Wirtz
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

5.  Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study.

Authors:  R C Wolfs; P H Borger; R S Ramrattan; C C Klaver; C A Hulsman; A Hofman; J R Vingerling; R A Hitchings; P T de Jong
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

6.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Authors:  Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2002-06

7.  A genomewide scan identifies novel early-onset primary open-angle glaucoma loci on 9q22 and 20p12.

Authors:  J L Wiggs; S Lynch; G Ynagi; M Maselli; J Auguste; E A Del Bono; L M Olson; J L Haines
Journal:  Am J Hum Genet       Date:  2004-04-23       Impact factor: 11.025

8.  Glaucoma phenotype in pedigrees with the myocilin Thr377Met mutation.

Authors:  David A Mackey; Danielle L Healey; John H Fingert; Michael A Coote; Tiffany L Wong; Colleen H Wilkinson; Paul J McCartney; Julian L Rait; A Pauline de Graaf; Edwin M Stone; Jamie E Craig
Journal:  Arch Ophthalmol       Date:  2003-08

9.  Changes in central corneal thickness over time: the ocular hypertension treatment study.

Authors:  James D Brandt; Mae O Gordon; Julia A Beiser; Shan C Lin; Monica Y Alexander; Michael A Kass
Journal:  Ophthalmology       Date:  2008-04-18       Impact factor: 12.079

10.  Investigation of founder effects for the Thr377Met Myocilin mutation in glaucoma families from differing ethnic backgrounds.

Authors:  Alex W Hewitt; John R Samples; R Rand Allingham; Irma Järvelä; George Kitsos; Subbaiah R Krishnadas; Julia E Richards; Paul R Lichter; Michael B Petersen; Periasamy Sundaresan; Janey L Wiggs; David A Mackey; Mary K Wirtz
Journal:  Mol Vis       Date:  2007-03-28       Impact factor: 2.367

View more
  1 in total

Review 1.  A molecular mechanism for glaucoma: endoplasmic reticulum stress and the unfolded protein response.

Authors:  Robert R H Anholt; Mary Anna Carbone
Journal:  Trends Mol Med       Date:  2013-07-19       Impact factor: 11.951

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.